Bacterial co-infection at hospital admission in patients with COVID-19. (May 2022)
- Record Type:
- Journal Article
- Title:
- Bacterial co-infection at hospital admission in patients with COVID-19. (May 2022)
- Main Title:
- Bacterial co-infection at hospital admission in patients with COVID-19
- Authors:
- Moreno-García, Estela
Puerta-Alcalde, Pedro
Letona, Laura
Meira, Fernanda
Dueñas, Gerard
Chumbita, Mariana
Garcia-Pouton, Nicole
Monzó, Patricia
Lopera, Carlos
Serra, Laia
Cardozo, Celia
Hernandez-Meneses, Marta
Rico, Verónica
Bodro, Marta
Morata, Laura
Fernandez-Pittol, Mariana
Grafia, Ignacio
Castro, Pedro
Mensa, Josep
Martínez, José Antonio
Sanjuan, Gemma
Marcos, Mª Angeles
Soriano, Alex
Garcia-Vidal, Carolina - Abstract:
- Highlights: Over 9% of patients hospitalized for COVID-19 will present a co-infection. Independent risk factors for co-infection were identified. When procalcitonin values are <0.2 ng/mL, co-infection is very rare. High ferritin values and oxygen saturation >94% are also uncommon in co-infection. ABSTRACT: Objectives: We described the current incidence and risk factors of bacterial co-infection in hospitalized patients with COVID-19. Methods: Observational cohort study was performed at the Hospital Clinic of Barcelona (February 2020–February 2021). All patients with COVID-19 who were admitted for >48 hours with microbiological sample collection and procalcitonin (PCT) determination within the first 48 hours were included. Results: A total of 1125 consecutive adults met inclusion criteria. Co-infections were microbiologically documented in 102 (9.1%) patients. Most frequent microorganisms were Streptococcus pneumoniae (79%), Staphylococcus aureus (6.8%), and Haemophilus influenzae (6.8%). Test positivity was 1% (8/803) for blood cultures, 10.1% (79/780) for pneumococcal urinary antigen test, and 11.4% (15/132) for sputum culture. Patients with PCT higher than 0.2, 0.5, 1, and 2 ng/mL had significantly more co-infections than those with lower levels (p=0.017, p=0.031, p<0.001, and p<0.001, respectively). In multivariate analysis, oxygen saturation ≤94% (OR 2.47, CI 1.57–3.86), ferritin levels <338 ng/mL (OR 2.63, CI 1.69–4.07), and PCT higher than 0.2 ng/mL (OR 1.74, CIHighlights: Over 9% of patients hospitalized for COVID-19 will present a co-infection. Independent risk factors for co-infection were identified. When procalcitonin values are <0.2 ng/mL, co-infection is very rare. High ferritin values and oxygen saturation >94% are also uncommon in co-infection. ABSTRACT: Objectives: We described the current incidence and risk factors of bacterial co-infection in hospitalized patients with COVID-19. Methods: Observational cohort study was performed at the Hospital Clinic of Barcelona (February 2020–February 2021). All patients with COVID-19 who were admitted for >48 hours with microbiological sample collection and procalcitonin (PCT) determination within the first 48 hours were included. Results: A total of 1125 consecutive adults met inclusion criteria. Co-infections were microbiologically documented in 102 (9.1%) patients. Most frequent microorganisms were Streptococcus pneumoniae (79%), Staphylococcus aureus (6.8%), and Haemophilus influenzae (6.8%). Test positivity was 1% (8/803) for blood cultures, 10.1% (79/780) for pneumococcal urinary antigen test, and 11.4% (15/132) for sputum culture. Patients with PCT higher than 0.2, 0.5, 1, and 2 ng/mL had significantly more co-infections than those with lower levels (p=0.017, p=0.031, p<0.001, and p<0.001, respectively). In multivariate analysis, oxygen saturation ≤94% (OR 2.47, CI 1.57–3.86), ferritin levels <338 ng/mL (OR 2.63, CI 1.69–4.07), and PCT higher than 0.2 ng/mL (OR 1.74, CI 1.11–2.72) were independent risk factors for co-infection at hospital admission owing to COVID-19. Conclusions: Bacterial co-infection in patients hospitalized for COVID-19 is relatively common. However, clinicians could spare antibiotics in patients with PCT values <0.2, especially with high ferritin values and oxygen saturation >94%. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 118(2022)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 118(2022)
- Issue Display:
- Volume 118, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 118
- Issue:
- 2022
- Issue Sort Value:
- 2022-0118-2022-0000
- Page Start:
- 197
- Page End:
- 202
- Publication Date:
- 2022-05
- Subjects:
- COVID-19 -- bacterial infection -- co-infection -- antibiotics -- SARS-CoV-2
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2022.03.003 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22278.xml